Healthline
January 18, 2025
Share on PinterestRecent reports on moderate alcohol consumption have left many people wondering whether it’s safe to drink at all. Studio Firma/Stocksy United A new federal […]
January 17, 2025
Share on PinterestRed dye No. 3 has been shown in animal studies to cause cancer. JurgaR/Getty Images The FDA issued a ban on the use of […]
January 17, 2025
Share on PinterestWhile overall cancer deaths are declining, a new report shows that cancer incidence is increasing in females and young people. Mariano Garcia Gaspar/Getty Images […]
January 16, 2025
Share on PinterestRed dye No. 3 has been shown in animal studies to cause cancer. JurgaR/Getty Images The FDA issued a ban on the use of […]
Medscape
January 17, 2025
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal […]
January 17, 2025
(Reuters) -Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do not inform patients of the risks […]
January 17, 2025
Cancer deaths have declined by more than a third since the 1990s, but the incidence of many cancer types in women and younger adults is increasing. […]
January 17, 2025
The number of women cardiologists presenting at grand rounds has increased steadily over 25 years in the United States, but in some subspecialties, women grand round […]
FDA
January 17, 2025
Mifeprex (mifepristone) and its generic, Mifepristone Tablets, 200 mg (collectively mifepristone) are approved, in a regimen with misoprostol, to end an intrauterine pregnancy through ten weeks […]
January 17, 2025
On August 31, 2021, the Food and Drug Administration approved zanubrutinib (Brukinsa, BeiGene) for adult patients with Waldenström’s macroglobulinemia (WM). Zanubrutinib was investigated in ASPEN (NCT03053440), […]
January 17, 2025
On January 17, 2025, the Food and Drug Administration approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo, Inc.), a Trop-2-directed antibody and topoisomerase inhibitor conjugate, for adult patients […]
January 17, 2025
Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership […]
